Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/2364| Title: | A prospective cohort study of men receiving irreversible electroporation (NanoKnife) for prostate cancer. |
| Epworth Authors: | Carll, Jonathon Lawrentschuk, Nathan Chengodu, Thili |
| Keywords: | Prospective Cohort Study Irreversible Electroporation NanoKnife Prostate Cancer Cancer IRE Oncology EJ Whitten Centre for Prostate Cancer Research, Epworth Freemasons, Epworth HealthCare, Victoria, Australia Urology and Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia Cancer Services Clinical Institute, Epworth HealthCare, Victoria, Australia |
| Issue Date: | Aug-2025 |
| Conference Name: | Epworth HealthCare Research Week 2025 |
| Conference Location: | Epworth Research Institute, Victoria, Australia |
| Abstract: | Irreversible Electroporation (IRE) also known as Nanoknife, is an emerging focal therapy used in the treatment of localised prostate cancer. It remains an investigational, technique with long-term oncological outcomes not yet well-established. This study assesses the initial experience from a prospectively collected database at a single institution. |
| URI: | http://hdl.handle.net/11434/2364 |
| Type: | Conference Poster |
| Affiliated Organisations: | University of Melbourne Department of Surgery, Victoria, Australia |
| Type of Clinical Study or Trial: | Cohort Study |
| Appears in Collections: | Epworth Prostate Centre Research Week UroRenal, Vascular |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| NK Research Week_Jonathon Carll.pdf | A Prospective Cohort Study of Men Receiving Irreversible Electroporation (NanoKnife) for Prostate Cancer | 277.71 kB | Adobe PDF |  View/Open |
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.